Eldis

Please note - this is a temporary window. id21 is joining forces with Eldis and therefore the id21 website has been suspended. Soon all id21 content will be available on the Eldis website.

Funding renal disease care in Thailand

When it started, Thailand’s universal health coverage scheme excluded treatment for end-stage renal disease on economic grounds. This had serious implications for poorer patients who could not afford expensive, life-saving treatment, and contradicted the principles of equity and protection from financial risk fundamental to the scheme. 

Research from the Thai Ministry of Public Health and the London School of Hygiene and Tropical Medicine assesses the medical and economic impacts of withholding free treatment for end-stage renal disease (ESRD). The authors offer alternatives that could help balance public policy goals of efficiency and equity.

Governments in low- and middle-income countries with limited health resources face the difficult decision of what to include in national health care benefit packages. Budget limitations, political pressure and public demand also influence these decisions. Thailand’s universal coverage (UC) scheme was set up in 2001 and covers 75 percent of the population.

Evidence suggested renal replacement therapy (RRT) was not cost-effective and could consume over 12 percent of national health expenditure. Therefore access to RRT for UC members depended on their ability to pay. The researchers studied 20 households affected by ESRD in urban and rural areas of Nakorn Ratchasima province. Findings included:

Excluding RRT from the health care scheme compromised UC policy goals. It was inequitable as beneficiaries under the two other public insurance schemes, Social Health Insurance and Civil Servant Medical Benefit Scheme, had full access to all RRT services. Since patients and their relatives were affected by medical costs, they were not protected from financial risk.

The Thai government should reconsider its decision not to support RRT, consulting with all major concerned groups. The researchers suggest four alternatives:

Source(s):
‘The Implications of Benefit Package Design: The Impact on Poor Thai Households of Excluding Renal Replacement Therapy’, Journal of International Development Vol.21, Issue.2, pages 291 to 308, by Phusit Prakongsai, Natasha Palmer, Preecha Uay-Trakul, Viroj Tangcharoensathien and Anne Mills, 2009

Funded by: World Health Organization

id21 Research Highlight: 1 June 2009

Further Information:
Phusit Prakongsai
International Health Policy Program
Ministry of Public Health
Muang District
Nonthaburi Province
Thailand 11000

Tel: +66 2 590 2366
Fax: +66 2 590 2385
Contact the contributor: phusit@ihpp.thaigov.net

International Health Policy Program, Ministry of Public Health, Thailand

Other related links:
'Prioritising reproductive health services in Thailand'

'Any volunteers? Extending voluntary health insurance in Vietnam'

'Health care reforms in Georgia: at what price?'

'Join the club: promoting enrolment in community health insurance in Burkina Faso'

'Informal health insurance in Rwanda: creating greater equity?'

'Universal coverage of health services: lessons from middle-income countries'

'Financing mental health services in low- and middle-income countries'

Views expressed on these pages are not necessarily those of DfID, IDS, id21 or other contributing institutions. Articles featured on the id21 site may be copied or quoted without restriction provided id21 and originating author(s) and institution(s) are acknowledged. Copyright © 2009 IDS. All rights reserved.

id21 is funded by the UK Department for International Development. id21 is one of a family of knowledge services at the Institute of Development Studies at the University of Sussex. id21 is a www.oneworld.net partner and an affiliate of www.mediachannel.org. IDS is a charitable company, No. 877338.